arginine has been researched along with celecoxib in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anton-Culver, H; Besselsen, DG; Gerner, EW; Ignatenko, NA; Yerushalmi, HF; Zell, JA; Ziogas, A | 1 |
| Acco, A; Alves da Silva, MH; Batista, MR; Bracht, A; Yamamoto, NS | 1 |
| Dehpour, AR; Hajimirzabeigi, A; Khalilzadeh, O; Maleki, F; Zandieh, A; Zandieh, B | 1 |
| Fomenko, IS; Panasyuk, NB; Sklyarov, AY | 1 |
| Abdel-Moneim, LM; Daabees, TT; Mohamed, HF; Omar, AG; Senbel, AM | 1 |
| Bauk, L; Drmic, D; Ilic, S; Kolenc, D; Luetic, K; Seiwerth, S; Sever, M; Sikiric, P; Suran, J; Zenko Sever, A | 1 |
| Demougeot, C; Marie, C; Prati, C; Prigent-Tessier, A; Totoson, P; Tournier-Nappey, M; Verhoeven, F; Wendling, D | 1 |
| Briggs, WTE; Castro, C; FitzGerald, GA; Griffin, JL; Karlson, EW; Lahens, NF; Li, X; Malik, D; Meng, H; Rhoades, SD; Ricciotti, E; Sparks, JA; Tang, SY; Weljie, AM; West, JA | 1 |
| Anderson, AJ; Dong, L; Malkowski, MG | 1 |
1 review(s) available for arginine and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for arginine and celecoxib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival.
Topics: Acetyltransferases; Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Celecoxib; Colonic Neoplasms; Colorectal Neoplasms; Eating; Female; Gene Expression; Humans; Male; Meat; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nitric Oxide Synthase Type II; Ornithine Decarboxylase; Polyamines; Pyrazoles; Risk Factors; Sulfonamides; Survival Analysis | 2007 |
Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Topics: Alanine; Ammonia; Animals; Arginine; Carcinoma 256, Walker; Celecoxib; Cyclooxygenase 2 Inhibitors; Gluconeogenesis; Glycolysis; In Vitro Techniques; Liver; Male; Neoplasm Transplantation; Perfusion; Pyrazoles; Rats; Sulfonamides; Urea | 2007 |
Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: Modulation by NO pathway.
Topics: Animals; Anticonvulsants; Arginine; Celecoxib; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Epilepsy; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrazoles; Statistics, Nonparametric; Sulfonamides | 2010 |
Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis.
Topics: Acetic Acid; Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Arginine; Benzoquinones; Celecoxib; Colitis, Ulcerative; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Female; Guanidines; Indomethacin; Intestine, Large; Leukotriene B4; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Pyrazoles; Rats; Sulfonamides | 2011 |
Evaluation of l-arginine on kidney function and vascular reactivity following ischemic injury in rats: protective effects and potential interactions.
Topics: Acetylcholine; Acute Kidney Injury; Animals; Antioxidants; Aorta; Arginine; Ascorbic Acid; Celecoxib; Cyclooxygenase 2; Drug Synergism; Kidney Function Tests; Nitric Oxide; Nitroprusside; Rats; Reactive Oxygen Species; Reperfusion Injury | 2014 |
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
Topics: Animals; Anti-Ulcer Agents; Antidotes; Arginine; Brain; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Stomach; Stomach Ulcer | 2017 |
Diclofenac but not celecoxib improves endothelial function in rheumatoid arthritis: A study in adjuvant-induced arthritis.
Topics: Animals; Aorta, Thoracic; Arginase; Arginine; Arthritis, Experimental; Biological Factors; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Endothelium, Vascular; Freund's Adjuvant; In Vitro Techniques; Male; NADPH Oxidases; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Inbred Lew; Vasodilation; Vasodilator Agents | 2017 |
Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Celecoxib; Creatinine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Placebo Effect | 2018 |
Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.
Topics: Animals; Arachidonic Acid; Arginine; Aspirin; Celecoxib; Crystallography, X-Ray; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Assays; Histidine; Hydroxyeicosatetraenoic Acids; Leucine; Mutagenesis, Site-Directed; Recombinant Proteins; Sf9 Cells; Stereoisomerism; Substrate Specificity; Time Factors | 2019 |